Genetic identification, sequence, and alternative splicing of the Caenorhabditis elegans alpha 2(IV) collagen gene - PubMed (original) (raw)

Genetic identification, sequence, and alternative splicing of the Caenorhabditis elegans alpha 2(IV) collagen gene

M H Sibley et al. J Cell Biol. 1993 Oct.

Abstract

The nematode Caenorhabditis elegans has two type IV collagen genes homologous to the mammalian alpha 1(IV) and alpha 2(IV) collagen genes. We demonstrate by transgenic rescue of mutant animals that the genetic locus encoding the C. elegans alpha 2(IV) collagen gene is let-2 on the X chromosome. The most severe effect of mutations in let-2 is temperature-sensitive embryonic lethality. The embryonic lethal phenotype is similar to that seen in animals with mutations in the alpha 1(IV) collagen gene, emb-9. The sequence of the entire C. elegans alpha 2(IV) collagen gene is presented. Comparisons with mammalian type IV collagen sequences show high amino acid sequence conservation in the C-terminal NCl domain and of crosslinking residues (Cys and Lys) in the N-terminal 7S domain. RT-PCR analysis shows that transcripts of the C. elegans alpha 2(IV) collagen gene are alternatively spliced. Transcripts contain one of two mutually exclusive exons, exon 9 or 10. These exons encode very similar products, differing primarily in the sequence of a 9-10 amino acid Gly-X-Y interruption. The expression of these alternatively spliced alpha 2(IV) collagen transcripts is developmentally regulated. In embryos over 90% of the alpha 2(IV) collagen mRNA contains exon 9, while larval and adult RNAs contain 80-90% exon 10. This shift in expression of alternative alpha 2(IV) collagen transcripts suggests that C. elegans embryos may require a different form of alpha 2(IV) collagen than do larvae and adults.

PubMed Disclaimer

Cited by

The in-silico characterization of the Caenorhabditis elegans matrisome and proposal of a novel collagen classification.
Teuscher AC, Jongsma E, Davis MN, Statzer C, Gebauer JM, Naba A, Ewald CY. Teuscher AC, et al. Matrix Biol Plus. 2019 Feb 21;1:100001. doi: 10.1016/j.mbplus.2018.11.001. eCollection 2019 Feb. Matrix Biol Plus. 2019. PMID: 33543001 Free PMC article.
Analysis of the role of Caenorhabditis elegans GC-AG introns in regulated splicing.
Farrer T, Roller AB, Kent WJ, Zahler AM. Farrer T, et al. Nucleic Acids Res. 2002 Aug 1;30(15):3360-7. doi: 10.1093/nar/gkf465. Nucleic Acids Res. 2002. PMID: 12140320 Free PMC article.
Characterization of alpha1(IV) collagen mutations in Caenorhabditis elegans and the effects of alpha1 and alpha2(IV) mutations on type IV collagen distribution.
Gupta MC, Graham PL, Kramer JM. Gupta MC, et al. J Cell Biol. 1997 Jun 2;137(5):1185-96. doi: 10.1083/jcb.137.5.1185. J Cell Biol. 1997. PMID: 9166417 Free PMC article.
Mutations in the alpha 2(IV) basement membrane collagen gene of Caenorhabditis elegans produce phenotypes of differing severities.
Sibley MH, Graham PL, von Mende N, Kramer JM. Sibley MH, et al. EMBO J. 1994 Jul 15;13(14):3278-85. doi: 10.1002/j.1460-2075.1994.tb06629.x. EMBO J. 1994. PMID: 8045258 Free PMC article.
COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets.
Kuo DS, Labelle-Dumais C, Gould DB. Kuo DS, et al. Hum Mol Genet. 2012 Oct 15;21(R1):R97-110. doi: 10.1093/hmg/dds346. Epub 2012 Aug 21. Hum Mol Genet. 2012. PMID: 22914737 Free PMC article. Review.

References

1. Genetics. 1974 May;77(1):71-94 - PubMed
1. J Biol Chem. 1993 Mar 5;268(7):5249-54 - PubMed
1. Genetics. 1978 Feb;88(2):285-303 - PubMed
1. Genetics. 1979 May;92(1):99-115 - PubMed
1. Dev Biol. 1980 Feb;74(2):446-69 - PubMed

Genetic identification, sequence, and alternative splicing of the Caenorhabditis elegans alpha 2(IV) collagen gene - PubMed (original) (raw)